| Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging Guidelines: Instrumentation, Acquisition, Processing, and Interpretation |
44 |
| ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging |
40 |
| Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC |
32 |
| Meta-analysis of 18F-FDG PET/CT in the diagnosis of infective endocarditis |
26 |
| Role of F-18-FDG PET/CT in the diagnosis of cardiovascular implantable electronic device infections: A meta-analysis |
21 |
| F-18-sodium fluoride positron emission tomography assessed microcalcifications in culprit and non-culprit human carotid plaques |
20 |
| Accuracy of 99mTc-Hydroxymethylene diphosphonate scintigraphy for diagnosis of transthyretin cardiac amyloidosis |
19 |
| Positron emission tomography (PET) utilizing Pittsburgh compound B (PIB) for detection of amyloid heart deposits in hereditary transthyretin amyloidosis (ATTR) |
18 |
| A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American Society of Nuclear Cardiology |
18 |
| State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis |
17 |
| Feasibility of FDG-PET in myocarditis: Comparison to CMR using integrated PET/MRI |
17 |
| Isolated cardiac sarcoidosis: A focused review of an under-recognized entity |
16 |
| Consistent tracer administration profile improves test-retest repeatability of myocardial blood flow quantification with Rb-82 dynamic PET imaging |
13 |
| Incremental role of resting myocardial computed tomography perfusion for predicting physiologically significant coronary artery disease: A machine learning approach |
12 |
| Recommendations for F-18-fluorodeoxyglucose positron emission tomography imaging for diagnosis of cardiac sarcoidosis-2018 update: Japanese Society of Nuclear Cardiology recommendations |
12 |
| Infections in patients using ventricular-assist devices: Comparison of the diagnostic performance of F-18-FDG PET/CT scan and leucocyte-labeled scintigraphy |
11 |
| Hybrid PET/CT and PET/MRI imaging of vulnerable coronary plaque and myocardial scar tissue in acute myocardial infarction |
11 |
| Assessment of attenuation correction for myocardial PET imaging using combined PET/MRI |
11 |
| Blood pool and tissue phase patient motion effects on (82)rubidium PET myocardial blood flow quantification |
11 |
| Partial volume correction for improved PET quantification in F-18-NaF imaging of atherosclerotic plaques |
11 |
| Role of cardiac I-123-mIBG imaging in predicting arrhythmic events in stable chronic heart failure patients with an ICD |
11 |
| Standardization of (99m)Technetium pyrophosphate imaging methodology to diagnose TTR cardiac amyloidosis |
10 |
| F-18 FDG PET for assessment of disease activity of large vessel vasculitis: A systematic review and meta-analysis |
10 |
| F-18-FDG PET/CT for the quantification of inflammation in large carotid artery plaques |
10 |
| (18)Fluorine sodium fluoride positron emission tomography, a potential biomarker of transthyretin cardiac amyloidosis |
10 |
| Relationship of myocardial hibernation, scar, and angiographic collateral flow in ischemic cardiomyopathy with coronary chronic total occlusion |
10 |
| The significance of post-stress decrease in left ventricular ejection fraction in patients undergoing regadenoson stress gated SPECT myocardial perfusion imaging |
9 |
| Radiopharmaceutical tracers for cardiac imaging |
8 |
| Guidelines in review: Comparison of ESC and ACC/AHA guidelines for the diagnosis and management of patients with stable coronary artery disease |
8 |
| Impact of regadenoson-induced myocardial creep on dynamic Rubidium-82 PET myocardial blood flow quantification |
8 |
| Regadenoson use in chronic kidney disease and end-stage renal disease: A focused review |
8 |
| Diagnostic and prognostic significance of transient ischemic dilation (TID) in myocardial perfusion imaging: A systematic review and meta-analysis |
7 |
| Advanced cardiovascular imaging for the evaluation of cardiac sarcoidosis |
7 |
| Comparison of maximal Rubidium-82 activitiesformyocardial blood flow quantification between digital and conventional PET systems |
7 |
| Negative predictive value of stress myocardial perfusion imaging and coronary computed tomography angiography: A meta-analysis |
7 |
| Dosimetry, biodistribution, and safety of flurpiridaz F 18 in healthy subjects undergoing rest and exercise or pharmacological stress PET myocardial perfusion imaging |
7 |
| In search of the vulnerable patient or the vulnerable plaque: F-18-sodium fluoride positron emission tomography for cardiovascular risk stratification |
7 |
| Left ventricular phase entropy: Novel prognostic predictor in patients with dilated cardiomyopathy and narrow QRS |
6 |
| Assessment of atherosclerotic plaque calcification using F18-NaF PET-CT |
6 |
| Automatic calculation of myocardial external efficiency using a single C-11-acetate PET scan |
6 |
| Heart failure patients with prediabetes and newly diagnosed diabetes display abnormalities in myocardial metabolism |
6 |
| Arterial inflammation in young patients with human immunodeficiency virus infection: A cross-sectional study using F-18 FDG PET/CT |
6 |
| Fully automated analysis of attenuation-corrected SPECT for the long-term prediction of acute myocardial infarction |
6 |
| Technical aspects of acquiring and measuring myocardial blood flow: Method, technique, and QA |
6 |
| Imaging cardiac innervation in amyloidosis |
5 |
| Relationship between left ventricular dyssynchrony and scar burden in the genesis of ventricular tachyarrhythmia |
5 |
| Association between non-perfusion parameters and presence of ischemia in gated-SPECT myocardial perfusion imaging studies |
5 |
| Prevalence and variability in reporting of clinically actionable incidental findings on attenuation-correction CT scans in a veteran population |
5 |
| Absolute quantification of myocardial blood flow |
5 |
| Prediction of cardiac death after adenosine myocardial perfusion SPECT based on machine learning |
5 |
